11/04/2025
🧬 Pharmacogenomics paves the way to stronger treatment for acute myeloid leukemia thanks to research conducted by PhD candidate Dr. Nadeen Anabtawi and Dr. Sharyn Baker, Gertrude Parker Heer Chair in Cancer Research and professor.
The duo completed a comprehensive study of the rare FLT3-JMD point mutation in collaboration with The Ohio State University Wexner Medical Center, unearthing answers to the mutation's mysteries.
"Studies like this bring us closer to truly personalized medicine, improving both the quality and precision of care that patients receive.”
Read about their discoveries at https://bit.ly/4qGml6c.